Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in type 2 diabetes
Open accessAbstract
Aims/hypothesis The aim of the study was to evaluate the relationship between insulin sensitivity, beta cell function and glucose tolerance, and its dependence on variants in the newly identified Type 2 diabetes susceptibility gene, calpain-10 ( CAPN10).Methods We studied 203 men of the same age but with varying degrees of glucose tolerance. These men participated in (i) an oral glucose tolerance test, (ii) a euglycaemic clamp combined with indirect calorimetry and infusion of [3-(3)H]-glucose and (iii) a stepwise assessment of acute insulin response to arginine (AIR) at three different glucose concentrations (fasting, 14 and 28 mmol/l).Results There was a linear increase in NEFA levels ( p<0.0005) and WHR ( p<0.0005) and decrease in glucose uptake due to a reduction in glucose storage over the entire range of glucose tolerance ( r=-0.404; p<0.005). No increase in endogenous glucose production (EGP) was seen until patients had manifest diabetes. However, when EGP was expressed relative to fasting insulin concentrations, there was a linear deterioration of basal hepatic insulin sensitivity ( r=-0.514; p<0.005). The AIR followed a bell-shaped curve with an initial rise and subsequent decrease. However, AIR adjusted for insulin sensitivity (disposition index) showed a linear decrease with increasing glucose concentrations ( r=-0.563; p<0.001) starting already in subjects with normal glucose tolerance. There was an inverse correlation between increase in WHR and NEFA and peripheral as well as hepatic insulin sensitivity. Subjects with the genotype combination of CAPN10 consisting of SNP44 TT and SNP43 GG genotypes had significantly lower insulin-stimulated glucose uptake than carriers of the other genotype combinations (5.3+/-0.4 vs 7.2+/-0.4 mg.ffm kg(-1).min(-1).mU.l(-1); p<0.005).Conclusions/interpretation We conclude that the pre-diabetic state is characterised by a similar linear deterioration of peripheral and hepatic insulin sensitivity as beta cell function and that variants in the CAPN10 gene modify this relationship. These findings are compatible with a common defect in muscle, liver and beta cells in the pathogenesis of Type 2 diabetes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Insulin resistance in muscle is the earliest demonstrable defect in the natural history of type 2 diabetes, but overt type 2 diabetes occurs only in individuals whose β-cells cannot compensate.
“Because the great majority of glucose disposal after intravenous glucose administration occurs in muscle, these results provide strong evidence that insulin resistance in muscle is the earliest demonstrable defect in the natural history of type 2 diabetes, but that the development of overt type 2 diabetes occurs only in those individuals whose β-cells are unable to compensate for the defect in”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [49]
The Introduction reports an earlier prospective study in which insulin sensitivity declined early and β-cell compensation failed later, before diabetes appeared. It does not establish muscle insulin resistance as the earliest defect; the Discussion instead describes parallel declines in insulin sensitivity and adjusted insulin secretion, and the paper notes that its cross-sectional design cannot establish their sequence. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · see citing works
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909 · see citing works
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · see citing works
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · see citing works
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · see citing works
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho‐Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,467 · see citing works
Self-citationMcGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435 · see citing works
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · see citing works
Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,328 · see citing works
Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · see citing works
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267 · see citing works
Krssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264 · see citing works
Eriksson, K. F., & Lindg�rde, F. (1991) · Diabetologia · doi:10.1007/bf00400196 · Cited by 1,092 · see citing works
Self-citationPerseghin, G., Scifo, P., De Cobelli, F., Pagliato, E., Battezzati, A., Arcelloni, C., Vanzulli, A., Testolin, G., Pozza, G., Del Maschio, A., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1600 · Cited by 877 · see citing works
Adipose tissue as a buffer for daily lipid flux
Frayn, K. (2002) · Diabetologia · doi:10.1007/s00125-002-0873-y · Cited by 752 · see citing works
Cline, G. W., Petersen, K. F., Krssak, M., Shen, J., Hundal, R. S., Trajanoski, Z., Inzucchi, S., Dresner, A., Rothman, D. L., & Shulman, G. I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410404 · Cited by 675 · see citing works
Jacob, S., Machann, J., Rett, K., Brechtel, K., Volk, A., Renn, W., Maerker, E., Matthaei, S., Schick, F., Claussen, C. D., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1113 · Cited by 643 · see citing works
Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483 · see citing works
Bogardus, C., Lillioja, S., Howard, B. V., Reaven, G. M., & Mott, D. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111533 · Cited by 397 · see citing works
Beck‐Nielsen, H., & Groop, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117518 · Cited by 336 · see citing works
Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.
Meyer, C., Stümvoll, M., Nadkarni, V., Dostou, J. M., Mitrakou, A., & Gerich, J. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2415 · Cited by 300 · see citing works
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
Baier, L. J., Permana, P. A., Yang, X., Pratley, R. E., Hanson, R. L., Shen, G.-Q., Mott, D. M., Knowler, W. C., Cox, N. J., Horikawa, Y., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10665 · Cited by 289 · see citing works
Troglitazone Lowers Islet Fat and Restores Beta Cell Function of Zucker Diabetic Fatty Rats
Shimabukuro, M., Zhou, Y.-T., Lee, Y., & Unger, R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3547 · Cited by 249 · see citing works
Evans, D. J., Murray, R., & Kissebah, A. H. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111565 · Cited by 201 · see citing works
Reaven, G. M., Hollenbeck, C. B., & Chen, Y. D. I. (1989) · Diabetologia · doi:10.1007/bf00265404 · Cited by 186 · see citing works
Eriksson, K.-F., & Lindg�rde, F. (1998) · Diabetologia · doi:10.1007/s001250051024 · Cited by 184 · see citing works
Self-citationEvans, J., Frayling, T. M., Cassell, P. G., Saker, P. J., Hitman, G. A., Walker, M., Lévy, J., O’Rahilly, S., Rao, P. V. S., Bennett, A. J., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323315 · Cited by 183 · see citing works
Calpains Play a Role in Insulin Secretion and Action
Sreenan, S., Zhou, Y.-P., Otani, K., Hansen, P. A., Currie, K., Pan, C., Lee, J.-P., Ostrega, D., Pugh, W., Horikawa, Y., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2013 · Cited by 180 · see citing works
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168 · see citing works
Analysis of techniques to obtain plasma for measurement of levels of free fatty acids
Zambon, A., Hashimoto, S., & Brunzell, J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39687-5 · Cited by 143 · see citing works
Groop, L., Wid�n, E., & Ferrannini, E. (1993) · Diabetologia · doi:10.1007/bf00400814 · Cited by 136 · see citing works
Self-citationDifferences in Insulin Suppression of Free Fatty Acid Levels by Gender and Glucose Tolerance Status
Laws, A., Hoen, H. M., Selby, J. V., Saad, M. F., Haffner, S. M., & Howard, B. V. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.64 · Cited by 128 · see citing works
Fatty acids in the portal vein of the rat regulate hepatic insulin clearance.
Svedberg, J., Strömblad, G., Wirth, A. G., Smith, U., & Björntorp, P. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115534 · Cited by 121 · see citing works
Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans
Baldeweg, S. E., Golay, Natali, A., Balkau, Prato, S. D., & Coppack, S. W. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00597.x · Cited by 121 · see citing works
Jeng, C.-Y., Sheu, W. H., Fuh, M. M.-T., Chen, Y. I., & Reaven, G. M. (1994) · Diabetes · doi:10.2337/diab.43.12.1440 · Cited by 118 · see citing works
Variants in the Calpain-10 Gene Predispose to Insulin Resistance and Elevated Free Fatty Acid Levels
Orho‐Melander, M., Klannemark, M., Svensson, M., Ridderstråle, M., Lindgren, C. M., & Groop, L. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2658 · Cited by 117 · see citing works
Self-citationMulder, H., Holst, L. S., Svensson, H. P., Degerman, E., Sundler, F., Åhrén, B., Rorsman, P., & Holm, C. (1999) · Diabetes · doi:10.2337/diabetes.48.1.228 · Cited by 110 · see citing works
Larsson, H. E., & Åhrén, B. (1998) · Diabetologia · doi:10.1007/s001250050986 · Cited by 103 · see citing works
Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism
Meyer, C., Dostou, J. M., Nadkarni, V., & Gerich, J. E. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.6.f915 · Cited by 102 · see citing works
Effects of Free Fatty Acids and Glucose on Splanchnic Insulin Dynamics
Hennes, M. M. I., Dua, A., & Kissebah, A. H. (1997) · Diabetes · doi:10.2337/diab.46.1.57 · Cited by 91 · see citing works
Härndahl, L., Jing, X., Ivarsson, R., Degerman, E., Åhrén, B., Manganiello, V. C., Renström, E., & Holst, L. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205401200 · Cited by 89 · see citing works
SNP43 of CAPN10 and the Risk of Type 2 Diabetes in African-Americans
Garant, M. J., Kao, W. H. L., Brancati, F. L., Coresh, J., Rami, T., Hanis, C. L., Boerwinkle, E., & Shuldiner, A. R. (2002) · Diabetes · doi:10.2337/diabetes.51.1.231 · Cited by 86 · see citing works
Båvenholm, P., Pigon, J., Östenson, C., & Efendić, S. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1449 · Cited by 81 · see citing works
Rasmussen, S. K., Urhammer, S. A., Berglund, L., Jensen, J. N., Hansen, L. B., Echwald, S. M., Borch‐Johnsen, K., Horikawa, Y., Mashima, H., Lithell, H., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3561 · Cited by 79 · see citing works
Tripathy, D., Carlsson, X. C. L., Lehto, M. J., Isomaa, B., Tuomi, T., & Groop, L. (2000) · Diabetologia · doi:10.1007/s001250051558 · Cited by 77 · see citing works
Self-citationHepatic glucose production in insulin‐resistant states
Ferrannini, E., & Groop, L. C. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050806 · Cited by 72 · see citing works
Self-citationFat‐Free Mass Qualitative Assessment with Bioelectric Impedance Analysis (BIA)
Talluri, T., LIETDKE, R. J., Evangelisti, A., Talluri, J., & Maggia, G. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09454.x · Cited by 61 · see citing works
Horikawa, Y., Oda, N., Yu, L., Imamura, S., Fujiwara, K., Makino, M., Seino, Y., Itoh, M., & Takeda, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020847 · Cited by 60 · see citing works
Role of pancreatic beta-cells in the process of beta-cell death.
PIPELEERS, D. G., Hoorens, A., Marichal-Pipeleers, M., de Casteele, M. V., Bouwens, L., & Ling, Z. C. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s52 · Cited by 59 · see citing works
Nielsen, O. H., Møngel, A., Møller, J., Rasmussen, O., Schmitz, O., & Beck‐Nielsen, H. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01903.x · Cited by 56 · see citing works
Time and dose dependencies for priming effect of glucose on insulin secretion
Grill, V. (1981) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1981.240.1.e24 · Cited by 54 · see citing works
Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients
Pigon, J., Giacca, A., Östenson, C. G., Lam, L., Vranić, M., & Efendić, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855826 · Cited by 40 · see citing works
Jeng, C. Y., Sheu, W. H., Fuh, M. M., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.12.1440 · Cited by 35 · see citing works
The effects of free fatty acids on glucose transport and phosphorylation in human skeletal muscle
Waldhäusl, W. K., & Roden, M. (2000) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200008000-00006 · Cited by 18 · see citing works
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7
Flagged first, then by citations
Cited by
Sorted by citations
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662 · see citing works
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · see citing works
“Because the great majority of glucose disposal after intravenous glucose administration occurs in muscle, these results provide strong evidence that insulin resistance in muscle is the earliest demonstrable defect in the natural history of type 2 diabetes, but that the development of overt type 2 diabetes occurs only…”
BackgroundSelf-citationMechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
Lyssenko, V., Lupi, R., Marchetti, P., Guerra, S. D., Orho‐Melander, M., Almgren, P., Sjögren, M., Ling, C., Eriksson, K., Lethagen, Υ.-L., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30706 · Cited by 821 · see citing works
Self-citationUtzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2009) · Diabetes Care · doi:10.2337/dc08-1478 · Cited by 572 · see citing works
Insulin Resistance and Type 2 Diabetes
Taylor, R. (2012) · Diabetes · doi:10.2337/db12-0073 · Cited by 394 · see citing works
Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease
Parekh, S., & Anania, F. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.055 · Cited by 340 · see citing works
Orho‐Melander, M., Melander, O., Guiducci, C., Pérez‐Martínez, P., Corella, D., Roos, C., Tewhey, R., Rieder, M. J., Hall, J. L., Abecasis, G. R., et al. (2008) · Diabetes · doi:10.2337/db08-0516 · Cited by 301 · see citing works
Self-citationComplementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23187 · Cited by 272 · see citing works
RetractedTaniguchi, C. M., Tran, T. T., Kondo, T., Luo, J., Ueki, K., Cantley, L. C., & Kahn, C. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604628103 · Cited by 155 · see citing works
Pathomechanisms of Type 2 Diabetes Genes
Staiger, H., Machicao, F. E., Fritsche, A., & Häring, H.-U. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0017 · Cited by 133 · see citing works
Defects in Insulin Secretion and Action in the Pathogenesis of Type 2 Diabetes Mellitus
Tripathy, D., & Chávez, A. O. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0115-5 · Cited by 123 · see citing works
Self-citationArsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus
Díaz‐Villaseñor, A., Burns, A. L., Hiriart, M., Cebrián, M. E., & Ostrosky‐Wegman, P. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.08.019 · Cited by 104 · see citing works
Bloem, C. J., & Chang, A. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1734 · Cited by 103 · see citing works
Getting ‘Smad’ about obesity and diabetes
Tan, C. K., Chong, H. C., Tan, E. H. P., & Tan, N. S. (2012) · Nutrition and Diabetes · doi:10.1038/nutd.2012.1 · Cited by 95 · see citing works
Utzschneider, K. M., Prigeon, R. L., Carr, D. B., Hull, R. L., Tong, J., Shofer, J. B., Retzlaff, B. M., Knopp, R. H., & Kahn, S. E. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1963 · Cited by 92 · see citing works
de Haan, W., Bhattacharjee, A., Ruddle, P., Kang, M. H., & Hayden, M. R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m045294 · Cited by 91 · see citing works
Common variants in HNF-1 α and risk of type 2 diabetes
Holmkvist, J., Cervin, C., Lyssenko, V., Winckler, W., Anevski, D., Cilio, C., Almgren, P.-E., Berglund, G., Nilsson, P. M., Tuomilehto, J., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0450-x · Cited by 92 · see citing works
Genes, Diet and Type 2 Diabetes Mellitus: A Review
Dedoussis, G. V., Kaliora, A. C., & Panagiotakos, D. B. (2007) · The Review of Diabetic Studies · doi:10.1900/rds.2007.4.13 · Cited by 87 · see citing works
Common Variants in Maturity-Onset Diabetes of the Young Genes and Future Risk of Type 2 Diabetes
Holmkvist, J., Almgren, P., Lyssenko, V., Lindgren, C. M., Eriksson, K., Isomaa, B., Tuomilehto, J., Nilsson, P. M., & Groop, L. (2008) · Diabetes · doi:10.2337/db06-1464 · Cited by 83 · see citing works
Self-citationNew type 2 diabetes risk genes provide new insights in insulin secretion mechanisms
Schäfer, S., Machicao, F. E., Fritsche, A., Häring, H., & Kantartzis, K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70008-0 · Cited by 78 · see citing works
Adipokines and Redox Signaling: Impact on Fatty Liver Disease
Parola, M., & Marra, F. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3848 · Cited by 59 · see citing works
Keildson, S., Fadista, J., Ladenvall, C., Hedman, Å. K., Elgzyri, T., Small, K. S., Grundberg, E., Nica, A. C., Glass, D., Richards, J. B., et al. (2013) · Diabetes · doi:10.2337/db13-1301 · Cited by 55 · see citing works
Self-citationChavez, A. O., Kamath, S., Jani, R., Sharma, L. K., Monroy, A., Abdul-Ghani, M. A., Centonze, V. E., Sathyanarayana, P., Coletta, D. K., Jenkinson, C. P., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1387 · Cited by 52 · see citing works
Self-citationKrishna, R., Herman, G. A., & Wagner, J. A. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9041-8 · Cited by 51 · see citing works
Goyal, S., Rani, J., Bhat, M. A., & Vanita, V. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i6.656 · Cited by 46 · see citing works
Merovci, A., Tripathy, D., Chen, X., Valdez, I., Abdul‐Ghani, M. A., Solis‐Herrera, C., Gastaldelli, A., & DeFronzo, R. A. (2020) · Diabetes · doi:10.2337/db20-0039 · Cited by 39 · see citing works
Self-citationSimmgen, M., Knauf, C., López, M., Choudhury, A. I., Charalambous, M., Cantley, J., Bedford, D. C., Claret, M., Iglesias, M. A., Heffron, H., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0084-4 · Cited by 36 · see citing works
Ahn, M., Oh, E., McCown, E. M., Wang, X., Veluthakal, R., & Thurmond, D. C. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154431 · Cited by 34 · see citing works
Briatore, L., Salani, B., Andraghetti, G., Maggi, D. C., Adami, G. F., Scopinaro, N., & Cordera, R. (2010) · Obesity · doi:10.1038/oby.2010.28 · Cited by 33 · see citing works
A common variant upstream of the PAX6 gene influences islet function in man
Ahlqvist, E., Turrini, F., Lang, S., Taneera, J., Zhou, Y., Almgren, P., Hansson, O., Isomaa, B., Tuomilehto, J., Eriksson, K., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2300-8 · Cited by 31 · see citing works
Self-citationCiresi, A., Amato, M. C., & Giordano, C. S. D. S. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0184-4 · Cited by 29 · see citing works
Chronic oral administration of arginine induces GH gene expression and insulin resistance
Barbosa, T. D. C., Poyares, L. L., Machado, U. F., & Nunes, M. T. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.04.004 · Cited by 29 · see citing works
Tripathy, D., Merovci, A., Basu, R., Abdul-Ghani, M. A., & DeFronzo, R. A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02304 · Cited by 28 · see citing works
Self-citationPoynten, A. M., Gan, S. K., Kriketos, A. D., Campbell, L. V., & Chisholm, D. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0943 · Cited by 28 · see citing works
Calpain-10 Expression Is Elevated in Pancreatic Islets from Patients with Type 2 Diabetes
Ling, C., Groop, L., Guerra, S. D., & Lupi, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006558 · Cited by 27 · see citing works
Self-citationGrenier–Larouche, T., Carreau, A., & Carpentier, A. C. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.10.013 · Cited by 26 · see citing works
Therapeutic potential of buckwheat hull flavonoids in db/db mice, a model of type 2 diabetes
Li, P., Tang, Y., Liu, L., Wang, D., Zhang, L., & Piao, C. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.11.011 · Cited by 26 · see citing works
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523187 · Cited by 23 · see citing works
Type 2 diabetes candidate gene CAPN10: First, but not last
Ridderstråle, M., & Nilsson, E. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0006-1 · Cited by 21 · see citing works
Ren, Z., Zhang, P., Zhang, X., Chen, S.-K., Zhang, H., Lv, D.-T., Zhuang, B.-Q., Wen, Y., Hu, H., Ding, W., et al. (2014) · Nutrition · doi:10.1016/j.nut.2014.10.012 · Cited by 21 · see citing works
Al‐Hakeim, H. K., & Abdulzahra, M. S. (2014) · Journal of Medical Biochemistry · doi:10.2478/jomb-2014-0033 · Cited by 21 · see citing works
Insulin secretion and sensitivity as determinants of HbA1c in type 2 diabetes
Monnier, L., Colette, C., Thuan, J., & Lapinski, H. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01623.x · Cited by 21 · see citing works
Lee, N., Park, S. J., Kang, D., Jeon, J. Y., Kim, H. J., Kim, D. J., Lee, K. W., Boyko, E. J., & Han, S. J. (2021) · Diabetes Care · doi:10.2337/dc21-1659 · Cited by 20 · see citing works
Lack of collagen XVIII leads to lipodystrophy and perturbs hepatic glucose and lipid homeostasis
Petäistö, T., Vicente, D., Mäkelä, K. A., Finnilä, M., Miinalainen, I., Koivunen, J. T., Izzi, V., Aikio, M., Karppinen, S., Devarajan, R., et al. (2020) · The Journal of Physiology · doi:10.1113/jp279559 · Cited by 19 · see citing works
PAS Kinase deficiency alters the glucokinase function and hepatic metabolism
Pérez-García, A., Dongil, P., Hurtado-Carneiro, V., Blázquez, E., Sanz, C., & Álvarez, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-29234-8 · Cited by 18 · see citing works
Roncero, I., Álvarez, E., Acosta, C., Sanz, C., Barrio, P. A., Hurtado-Carneiro, V., Burks, D. J., & Blázquez, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058797 · Cited by 16 · see citing works
Pérez-García, A., Hurtado-Carneiro, V., Herrero-de-Dios, C. M., Dongil, P., García‐Mauriño, J. E., Sánchez, M. D., Sanz, C., & Álvarez, E. (2021) · Nutrients · doi:10.3390/nu13082552 · Cited by 15 · see citing works
Calpain-10 and Adiponectin Gene Polymorphisms in Korean Type 2 Diabetes Patients
Nam, J. S., Han, J. W., Lee, S. B., You, J. H., Kim, M. J., Kang, S., Park, J. S., & Ahn, C. W. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.3.364 · Cited by 14 · see citing works
Kim, K., Kim, H. Y., Son, E., Heo, J., & Cheong, J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.03.019 · Cited by 14 · see citing works
Grunnet, L. G., Laurila, E., Hansson, O., Almgren, P., Groop, L., Brøns, C., Poulsen, P., & Vaag, A. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2061 · Cited by 14 · see citing works
Self-citationGuardado‐Mendoza, R., Chávez, A. O., Jiménez-Ceja, L. M., HANSIS-DIARTE, A. A., DeFronzo, R. A., Folli, F. B., & Tripathy, D. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0904-7 · Cited by 8 · see citing works
Self-citationThe metabolic outcomes of growth hormone treatment in children are gender specific
Ciresi, A., Radellini, S., Guarnotta, V., Mineo, M. G., & Giordano, C. S. D. S. (2018) · Endocrine Connections · doi:10.1530/ec-18-0135 · Cited by 8 · see citing works
Pathophysiology of Type 2 Diabetes
Kesavadev, J., Jawad, F., Deeb, A., Coetzee, A., Ansari, M., Shrestha, D., Somasundaram, N. P., & Kalra, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_9 · Cited by 8 · see citing works
Current approaches in CRISPR-Cas systems for diabetes
Arivarasan, V. K., Diwakar, D., Kamarudheen, N., & Karthik, L. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.08.002 · Cited by 6 · see citing works
Lay, A. L., Philippe, E., Roth, F., Sánchez-Archidona, A. R., Mehl, F., Denom, J., Prasad, R. B., Asplund, O., Hansson, O., Ibberson, M. R., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09944 · Cited by 5 · see citing works
Popović, L., Zamaklar, M., Lalic, K. S., & Vasović, O. (2006) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0606219p · Cited by 4 · see citing works
Pathophysiology of Type 2 Diabetes
Kesavadev, J., Jawad, F., Deeb, A., Coetzee, A., Ansari, M., Shrestha, D., Somasundaram, N. P., & Kalra, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_8 · Cited by 3 · see citing works
Role of Nutrient and Energy Sensors in the Development of Type 2 Diabetes
Hurtado-Carneiro, V., Pérez-García, A., Álvarez, E., & Sanz, C. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95454 · Cited by 2 · see citing works
Morbus Addison und pluriglanduläre Syndrome
Hansen, M. P., Erlich, M., & Kahaly, G. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2 · see citing works
Effects of Chronic Electronic Cigarette Use on Glucose Metabolism
Hoskinson, H. (2017) · doi:10.33915/etd.5823 · Cited by 2 · see citing works
Genes and Gene–Environment Interactions in the Pathogenesis of Obesity and the Metabolic Syndrome
Sanoudou, D., Vafiadaki, E., & Mantzoros, C. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-453-1_2 · Cited by 1 · see citing works
Böttcher, Y., Kovacs, P. L., Tönjes, A., & Stümvoll, M. (2005) · Der Internist · doi:10.1007/s00108-005-1434-5 · Cited by 1 · see citing works
Integrated characterization of cellular physiology underlying hepatic metabolism
Wong, M. S. (2006) · DSpace@MIT (Massachusetts Institute of Technology)
Regulation of renal brush-border glucose transport in response to metabolic dysregulation
Chichger, H. (2011) · UCL Discovery (University College London)
Estudio del factor de transcripción SREBP1 en estados de resistencia a insulina.
Miralles, S. V. (2007) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Utzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2008)
The Effect of Ginseng (The Genus Panax) on Glycemic and Vascular Health
Shishtar, A. H. A. M. E. (2014) · TSpace (University of Toronto)
Czerwinski, E. P. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Genetic Basis for Increased Risk for Vascular Diseases in Diabetes
Bharadwaj, D., & Singh, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_2
Yu, T., Li, M., Dong, H., Xie, P., Sun, W., Meng, B., & Mu, Y. (2018) · Archives of Biological Sciences · doi:10.2298/abs180705040y
Biomarker in insulin resistant and its complication.
Banu, N., Elango, K., & Rajendran, A. (2019) · Biomedical Research · doi:10.35841/biomedicalresearch.30-19-840
Current literature in diabetes
(2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.548
- Authors
- Tripathy, D., Eriksson, K. F., Orho-Melander, M., Fredriksson, J., Ahlqvist, G., & Groop, L.
- Affiliations
- Lund University (SE)
- Corresponding author
- Groop, L.
- Venue
- Diabetologia
- Published
- 2004-05-01
- Volume
- 47
- Issue
- 5
- Pages
- 782-793
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2104640556
- Cited by
- 74
- References
- 54
- Citations by year
- 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 1 · 2014: 5 · 2013: 3 · 2012: 3
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Novo Nordisk
- Medical Research Council
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Calpain Protease Function and Regulation
- Keywords
- type 2 diabetes, insulin resistance, beta-cell dysfunction, CAPN10, genetic susceptibility, glucose tolerance, hepatic insulin sensitivity, peripheral insulin sensitivity, endogenous glucose production, disposition index, waist-to-hip ratio, free fatty acids, prediabetes, glucose uptake, euglycaemic clamp
- MeSH terms
- Adult, Aged, Blood Glucose, Calpain, Diabetes Mellitus, Exercise Test, Fatty Acids, Nonesterified, Genotype, Glucose, Glucose Tolerance Test, Humans, Insulin Resistance, Islets of Langerhans, Oxygen Consumption, Glucose Clamp Technique, Glucose Intolerance, Genetic Predisposition to Disease, Body Size
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review